Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03957915
Title Study of Escalating Doses of INA03 Administered Intravenously as Single Agent in Adult Patients With Relapse/Refractory Acute Leukemia (INA03)
Acronym INA03
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Institut Paoli-Calmettes
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA


No variant requirements are available.